Circulating endothelial progenitor cells (EPCs) are reduced in hypertension, which inversely correlates with its mortality. DOCA–salt hypertension features elevated ET-1 and oxidative stress. We tested the hypothesis that ET-1 induces EPC dysfunction by elevating oxidative stress through the ETA/NADPH oxidase pathway in salt-sensitive hypertension. Both ETA and ETB receptors were expressed in EPCs, but only ETA receptors were significantly increased in EPCs of DOCA-salt rats. EPC number and function were reduced in DOCA-salt rats compared with Sham controls, both were reversed by in vivo blockade of ETA receptors or NADPH oxidase. The enzymatic activity of NAPDH oxidase and its subunits gp91phox, p22phox and Rac1 were augmented in EPCs of DOCA-salt rats, with concomitantly decreased antioxidant enzymes MnSOD, CuZnSOD, and GPx-1. ROS level was elevated in EPCs from DOCA-salt rats, accompanied by increased EPC telomerase inactivation, senescence and apoptosis, which were rescued by ETA or NADPH oxidase blockade. Cell therapy of normal or treated DOCA EPCs, but not untreated DOCA EPCs, significantly increased capillary density and blood perfusion in ischemic hindlimbs of DOCA-salt rats. p53 and Bax/Bcl-2 ratios were increased in EPCs of DOCA-salt rats, which were reversed by ETA antagonist or NADPH oxidase inhibitor or superoxide scavenger (PEG-SOD). Finally, in ETB-deficient rats, plasma ET-1 was elevated and EPC number and telomerase activity were diminished. These results demonstrate, for the first time, that ET-1 contributes to EPC reduction and dysfunction via an ETA/NADPH oxidase pathway-induced oxidative stress in salt-sensitive hypertension.